NEW YORK (GenomeWeb) – Aviva Systems Biology said today it has acquired protein tools firm GenWay Biotech.

In a statement, Aviva CEO Peter Jiang described the purchase as part of his company's larger plan to "become a leading provider of proteomic solutions," and cited GenWay's experience and assets in protein, antibody, and ELISA production for both the research and clinical markets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.

Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.